IP Library Granted Patent US 10,487,345
Granted Patent B2
US 10,487,345 · App. 15/307,616 · Granted Nov 26, 2019

Methods for making and using polynucleotide sequences in the synthesis of alkaloid compounds

Inventor: Peter James Facchini (Calgary, CA)
Assignee: Epimeron Inc.
C12P17/12C12N9/0071C12N15/1082C12N15/81C12Y201/01C12N15/1096C12N15/63C40B10/00C40B20/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,487,345
App. No.
15/307,616
Granted
Nov 26, 2019
Kind
B2
Abstract

Novel methods that may be used for the manufacture of plant alkaloid compounds and novel polynucleotide compounds are provided. The plant alkaloid compounds are useful as medicinal compounds.

Claims (24)

1. A method of producing sanguinarine in a yeast host cell, the method comprising:

(a) providing a yeast host cell that expresses the enzymes Papaver somniferum 6-O-methyltransferase (6OMT), Papaver somniferum coclaurine-N-methyltransfersase (CNMT), Papaver somniferum 4′-O-methyltransferase 2 (4′OMT2), Papaver somniferum berberine bridge enzyme (BBE), cheilanthifoline synthase (CFS), Papaver somniferum stylopine synthase (SPS), Papaver somniferum tetrahydroprotoberberine cis-N-methyltransfersase (TNMT), Papaver somniferum (S)-cis-N-methylstylopine-14-hydroxylase (MSH), Papaver somniferum protopine 6-hydroxylase (6PH) and Papaver somniferum dihydrobenzoreductase (DBOX), and wherein the cheilanthifoline synthase is encoded by SEQ ID NO: 262, and

(b) growing the yeast cell to produce sanguinarine.

2. A method of producing sanguinarine in a yeast host cell, the method comprising:

(a) providing a yeast cell that expresses the enzymes Papaver somniferum 6-O-methyltransferase (6OMT), Papaver somniferum coclaurine-N-methyltransfersase (CNMT), Papaver somniferum 4′-O-methyltransferase 2 (4′OMT2), Papaver somniferum berberine bridge enzyme (BBE), Papaver somniferum cheilanthifoline synthase (CFS), stylopine synthase (SPS), Papaver somniferum tetrahydroprotoberberine cis-N-methyltransfersase (TNMT), Papaver somniferum (S)-cis-N-methylstylopine-14-hydroxylase (MSH), Papaver somniferum protopine 6-hydroxylase (6PH) and Papaver somniferum dihydrobenzoreductase (DBOX), and wherein the stylopine synthase (SPS) is encoded by SEQ ID NO: 264, and

(b) growing the yeast cell to produce sanguinarine.

3. A method of producing sanguinarine in a yeast host cell, the method comprising:

(a) providing a yeast host cell that expresses the enzymes Papaver somniferum 6-O-methyltransferase (6OMT), Papaver somniferum coclaurine-N-methyltransfersase (CNMT), Papaver somniferum 4′-O-methyltransferase 2 (4′OMT2), Papaver somniferum berberine bridge enzyme (BBE), cheilanthifoline synthase (CFS), stylopine synthase (SPS), Papaver somniferum tetrahydroprotoberberine cis-N-methyltransfersase (TNMT), Papaver somniferum (S)-cis-N-methylstylopine-14-hydroxylase (MSH), Papaver somniferum protopine 6-hydroxylase (6PH) and Papaver somniferum dihydrobenzoreductase (DBOX), and wherein the cheilanthifoline synthase (CFS) is encoded by SEQ ID NO: 262 and the stylopine synthase (SPS) is encoded by SEQ ID NO: 264, and

(b) growing the yeast cell to produce sanguinarine.

4. The method according to claim 1 , wherein the yeast cell is a Saccharomyces cell.

5. The method according to claim 2 , wherein the yeast cell is a Saccharomyces cell.

6. The method according to claim 4 , wherein the Saccharomyces cell is a Saccharomyces cerevisiae cell.

7. The method according to claim 5 , wherein the Saccharomyces cell is a Saccharomyces cerevisiae cell.

8. The method according to claim 3 , wherein the yeast cell is a Saccharomyces cell.

9. The method according to claim 8 , wherein the Saccharomyces cell is a Saccharomyces cerevisiae cell.

10. A method of producing sanguinarine in a Saccharomyces cerevisiae cell, the method comprising:

(a) providing a Saccharomyces cerevisiae cell that expresses the enzymes 6-O-methyltransferase (6OMT), coclaurine-N-methyltransfersase (CNMT), 4′-O-methyltransferase 2 (4′OMT2), berberine bridge enzyme (BBE), cheilanthifoline synthase (CFS), stylopine synthase (SPS), tetrahydroprotoberberine cis-N-methyltransfersase (TNMT), (S)-cis-N-methylstylopine-14-hydroxylase (MSH), protopine 6-hydroxylase (6PH) and dihydrobenzoreductase (DBOX), and wherein the cheilanthifoline synthase (CFS) is encoded by SEQ ID NO: 262 and is non-homologous to the other enzymes, and

(b) growing the Saccharomyces cerevisiae cell to produce sanguinarine wherein sanguinarine is produced in the cell at a level that is in excess of the level of sanguinarine produced when a homologous CFS is used.

11. A method of producing sanguinarine in a Saccharomyces cerevisiae cell, the method comprising:

(a) providing a Saccharomyces cerevisiae cell that expresses the enzymes 6-O-methyltransferase (6OMT), coclaurine-N-methyltransfersase (CNMT), 4′-O-methyltransferase 2 (4′OMT2), berberine bridge enzyme (BBE), cheilanthifoline synthase (CFS), stylopine synthase (SPS), tetrahydroprotoberberine cis-N-methyltransfersase (TNMT), (S)-cis-N-methylstylopine-14-hydroxylase (MSH), protopine 6-hydroxylase (6PH) and dihydrobenzoreductase (DBOX), and wherein the stylopine synthase (SPS) is encoded by SEQ ID NO: 264 and is non-homologous to the other enzymes, and

(b) growing the Saccharomyces cerevisiae cell to produce sanguinarine wherein sanguinarine is produced in the cell at a level that is in excess of the level of sanguinarine produced when a homologous SPS is used.

12. A method of producing sanguinarine in a Saccharomyces cerevisiae cell, the method comprising:

(a) providing a Saccharomyces cerevisiae cell that expresses the enzymes 6-O-methyltransferase (6OMT), coclaurine-N-methyltransfersase (CNMT), 4′-O-methyltransferase 2 (4′OMT2), berberine bridge enzyme (BBE), cheilanthifoline synthase (CFS), stylopine synthase (SPS), tetrahydroprotoberberine cis-N-methyltransfersase (TNMT), (S)-cis-N-methylstylopine-14-hydroxylase (MSH), protopine 6-hydroxylase (6PH) and dihydrobenzoreductase (DBOX), and wherein the cheilanthifoline synthase is encoded by SEQ ID NO: 262 and the stylopine synthase (SPS) is encoded by SEQ ID NO: 264 and both the CFS and SPS are non-homologous to the other enzymes, and

(b) growing the Saccharomyces cerevisiae cell to produce sanguinarine wherein sanguinarine is produced in the cell at a level that is in excess of the level of sanguinarine produced when a homologous CFS and SPS is used.

Assignments (7)
SECURITY INTEREST Recorded Aug 29, 2025
From: ANTHEIA, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 072750/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: WILLOW BIOSCIENCES, INC.
To: ANTHEIA, INC.
Reel/Frame 070785/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2021
From: ELESZTO GENETIKA, INC.
To: ANTHEIA, INC.
Reel/Frame 055485/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2020
From: WILLOW BIOSCIENCES, INC.
To: ELESZTO GENETIKA INC.
Reel/Frame 054082/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2019
From: EPIMERON INC.
To: WILLOW BIOSCIENCES INC.
Reel/Frame 050970/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2016
From: FACCHINI, PETER J.
To: UTI LIMITED PARTNERSHIP
Reel/Frame 040533/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2016
From: UTI LIMITED PARTNERSHIP
To: EPIMERON INC.
Reel/Frame 040533/0209 →
Continuity (3)
Provisional Application 61985742 · Apr 29, 2014
Provisional Application 62094376 · Dec 19, 2014
Related Publication 20170058305A1 · Mar 2, 2017